Research

During the last few decades the requirements for admission and registration of medicines have risen constantly. The aim of these requirements is to guarantee the quality, safety and efficacy of medicines. PADMA Inc. gives top priority of making Tibetan medicinal products available to western patients within this regulatory framework.

PADMA pharmaceutical formulae are tested in line with the regulations for their safety and tolerability. Numerous experimental studies and clinical trials research effects and mechanisms of action as well as the efficacy of the products. Researchers are currently working with PADMA formulas in universities and clinics in Switzerland, Austria, Germany, Denmark, Israel and other countries.

Studies of PADMA products are available for the following conditions:

• Peripheral arterial occlusive disease (PAOD, intermittent claudication)
• Recurring respiratory tract infections
• Chronic Hepatitis B
• Juvenile chronic arthritis
• Digestive problems, constipation, flatulence, irritable bowel syndrome

Medical professionals can examine these studies here.

Development

PADMA Inc. is committed to develop and register further effective medicines. The collaboration with Tibetan physicians is thereby of great importance as their knowledge and expertise supports PADMA Inc. to develop new products based on Tibetan medicine for the Western needs. The exchange of know-how merges in an ideal way Western quality standards, modern production methods with a well traditional holistic medical system.